KACTUS has developed two transmembrane protein display platforms: virus-like particles (VLPs) and nanodiscs.
KACTUS: Transmembrane Proteins

KACTUS has developed two transmembrane protein display platforms: virus-like particles (VLPs) and nanodiscs.
KACTUS have developed a series of immune checkpoint proteins with various tags.
KACTUS has developed a full portfolio of tag-free or small-tag cytokines with verified cellular-level bioactivity for various cell culture applications.
KACTUS provides a variety of highly active CD3 proteins, including monomers, dimers, and other forms, to meet the diverse needs of researchers.
KACTUS’ high-quality CD19 proteins are designed for applications such as antibody screening, CAR-T cell therapy development and affinity measurements.
KACTUS has demonstrated via ELISA & SPR binding assays that their MHC-peptide complexes & loaded peptide-ready MHCs have good binding affinity to TCRs.
KACTUS have a range of Class I and Class II MHC Monomer and Tetramer alleles available.